FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W69346578> ?p ?o ?g. }

• W69346578 endingPage "33" @default.
• W69346578 startingPage "223" @default.
• W69346578 abstract "Mechanical stimuli are known to have major influences on chondrocyte function. The molecular events that regulate chondrocyte responses to mechanical stimulation have been the subject of much study. Using an in vitro experimental system we have identified mechanotransduction pathways that control molecular and biochemical responses of human articular chondrocytes to cyclical mechanical stimulation, and how these responses differ in cells isolated from diseased cartilage. We have previously shown that mechanical stimulation of normal articular chondrocytes leads to a cell membrane hyperpolarisation. Within 1 hour following mechanical stimulation there is an increase in aggrecan mRNA levels. These responses are mediated via alpha5beta1 integrins, the neuropeptides substance P and NMDA, and the cytokine interleukin-4. In OA chondrocytes mechanical stimulation leads to cell membrane depolarisation, but no change in aggrecan mRNA at 1 hour. The depolarisation response is mediated via alpha5beta1 integrins, substance P and interleukin-4, but the cells show an altered response to NMDA. Having identified that the NMDA receptor is present in human articular cartilage and may play an important role in a chondroprotective mechanotransduction pathway, we were interested in whether other components associated with NMDA signalling may be involved in the chondrocyte mechanotransduction pathways. One such component is calcium/calmodulin-dependent protein kinase II (CaMKII). CaMKII mediates many cellular responses to elevated Ca2+ in a wide variety of cells and tissues. It is involved in the regulation of ion channels, cytoskeletal dynamics, gene transcription, neurotransmitter synthesis, insulin secretion, and cell division. CaMKII also shows a broad substrate specificity and is abundant in brain tissue, indicating that this kinase may play a number of roles in the functioning of the central nervous system. This kinase has been studied extensively in brain, but there is only a limited understanding of CaMKII in other tissues. CAMKII has four subunit isoforms (alpha,beta,gamma,delta). The alpha- and beta-isoforms have narrow distributions restricted mainly to neuronal tissues, but the gamma- and delta-isoforms are ubiquitously expressed within neuronal and non-neuronal tissues. The aim of this study was to investigate the expression of CaMKII in normal and OA cartilage and chondrocytes, and whether this enzyme is involved in the response of chondrocytes to cyclical mechanical stimuli. Reverse transcriptase-polymerase chain reaction (RT-PCR), using primers specific for the different CaMKII isoforms, was carried out to assess which isoforms are expressed in human articular chondrocytes. To assess whether CaMKII is expressed in human articular chondrocytes at the protein level, cultured chondrocytes were extracted and analysed by Western blotting using a pan-CaMKII antibody. Immunohistochemistry was carried out to investigate whether CaMKII is expressed by human articular chondrocytes in vivo. Frozen sections of normal, OA and ankle cartilage were incubated for one hour with CaMKII antibody and visualised using ABC and DAB. To assess the role of CaMKII in the mechanotransduction responses of normal and OA chondrocytes, human normal and OA articular chondrocytes were mechanically stimulated at 0.33 Hz, or by addition of recombinant IL-4 for 20 minutes. Cell responses to these stimuli, in the absence or presence of an inhibitor of CaMKII were assessed by measuring changes in cell membrane potential or changes in relative levels of aggrecan mRNA compared with the housekeeping gene GAPDH. Normal, OA, and ankle chondrocytes expressed the gamma and delta isoforms of CaMKII mRNA, but not the alpha and beta isoforms as demonstrated by RT-PCR. Western blotting showed a band at approximately 60 kDa consistent with the expression of CaMKII. Immunohistochemistry revealed the positive staining in the middle and deep zones, but not the superficial zone, of normal, OA, and ankle cartilage. The presence of a CaMKII inhibitor inhibits the membrane hyperpolarisation response and upregulation of aggrecan mRNA in normal chondrocytes following mechanical stimulation, but has no effect on the hyperpolarisation response to recombinant IL4. The depolarisation response of OA chondrocytes to mechanical stimulation is unaffected by the presence of the CaMKII inhibitor. The CaMKII isoforms gamma and delta are expressed in both normal and OA chondrocytes, both in vitro and in vivo, but are only involved in the response of normal chondrocytes to mechanical stimulation. This response is upstream of the effect of IL4. These findings are consistent with previous findings for the NMDA receptor, and suggest that dysregulation of NMDA-CaMKII signalling may be important in onset and progression of osteoarthritis." @default.
• W69346578 created "2016-06-24" @default.
• W69346578 creator A5000966945 @default.
• W69346578 creator A5003084842 @default.
• W69346578 creator A5039338150 @default.
• W69346578 creator A5059459855 @default.
• W69346578 creator A5089381837 @default.
• W69346578 date "2006-08-17" @default.
• W69346578 modified "2023-09-23" @default.
• W69346578 title "Calcium/calmodulin-dependent protein kinase II in human articular chondrocytes." @default.
• W69346578 cites W1968473165 @default.
• W69346578 cites W1970889097 @default.
• W69346578 cites W1981113633 @default.
• W69346578 cites W1999770057 @default.
• W69346578 cites W2017583361 @default.
• W69346578 cites W2037754231 @default.
• W69346578 cites W2042045265 @default.
• W69346578 cites W2072339114 @default.
• W69346578 cites W2079357592 @default.
• W69346578 cites W2088466489 @default.
• W69346578 cites W2093509637 @default.
• W69346578 cites W2099769743 @default.
• W69346578 cites W2112378103 @default.
• W69346578 cites W2134812217 @default.
• W69346578 cites W2165711586 @default.
• W69346578 cites W2188443210 @default.
• W69346578 cites W2416387298 @default.
• W69346578 cites W2466345400 @default.
• W69346578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16912396" @default.
• W69346578 hasPublicationYear "2006" @default.
• W69346578 type Work @default.
• W69346578 sameAs 69346578 @default.
• W69346578 citedByCount "12" @default.
• W69346578 countsByYear W693465782013 @default.
• W69346578 countsByYear W693465782014 @default.
• W69346578 countsByYear W693465782015 @default.
• W69346578 countsByYear W693465782016 @default.
• W69346578 countsByYear W693465782017 @default.
• W69346578 countsByYear W693465782021 @default.
• W69346578 crossrefType "journal-article" @default.
• W69346578 hasAuthorship W69346578A5000966945 @default.
• W69346578 hasAuthorship W69346578A5003084842 @default.
• W69346578 hasAuthorship W69346578A5039338150 @default.
• W69346578 hasAuthorship W69346578A5059459855 @default.
• W69346578 hasAuthorship W69346578A5089381837 @default.
• W69346578 hasConcept C105702510 @default.
• W69346578 hasConcept C142724271 @default.
• W69346578 hasConcept C169760540 @default.
• W69346578 hasConcept C181104049 @default.
• W69346578 hasConcept C185592680 @default.
• W69346578 hasConcept C197534660 @default.
• W69346578 hasConcept C204787440 @default.
• W69346578 hasConcept C24998067 @default.
• W69346578 hasConcept C2776164576 @default.
• W69346578 hasConcept C2780550940 @default.
• W69346578 hasConcept C2781403057 @default.
• W69346578 hasConcept C3020332539 @default.
• W69346578 hasConcept C71924100 @default.
• W69346578 hasConcept C86803240 @default.
• W69346578 hasConcept C95444343 @default.
• W69346578 hasConceptScore W69346578C105702510 @default.
• W69346578 hasConceptScore W69346578C142724271 @default.
• W69346578 hasConceptScore W69346578C169760540 @default.
• W69346578 hasConceptScore W69346578C181104049 @default.
• W69346578 hasConceptScore W69346578C185592680 @default.
• W69346578 hasConceptScore W69346578C197534660 @default.
• W69346578 hasConceptScore W69346578C204787440 @default.
• W69346578 hasConceptScore W69346578C24998067 @default.
• W69346578 hasConceptScore W69346578C2776164576 @default.
• W69346578 hasConceptScore W69346578C2780550940 @default.
• W69346578 hasConceptScore W69346578C2781403057 @default.
• W69346578 hasConceptScore W69346578C3020332539 @default.
• W69346578 hasConceptScore W69346578C71924100 @default.
• W69346578 hasConceptScore W69346578C86803240 @default.
• W69346578 hasConceptScore W69346578C95444343 @default.
• W69346578 hasIssue "3,4" @default.
• W69346578 hasLocation W693465781 @default.
• W69346578 hasOpenAccess W69346578 @default.
• W69346578 hasPrimaryLocation W693465781 @default.
• W69346578 hasRelatedWork W1504223844 @default.
• W69346578 hasRelatedWork W1784169729 @default.
• W69346578 hasRelatedWork W1968097552 @default.
• W69346578 hasRelatedWork W1996255356 @default.
• W69346578 hasRelatedWork W2022783020 @default.
• W69346578 hasRelatedWork W2061678562 @default.
• W69346578 hasRelatedWork W2067301526 @default.
• W69346578 hasRelatedWork W2067841245 @default.
• W69346578 hasRelatedWork W2072339114 @default.
• W69346578 hasRelatedWork W2074410400 @default.
• W69346578 hasRelatedWork W2075899672 @default.
• W69346578 hasRelatedWork W2085687131 @default.
• W69346578 hasRelatedWork W2105577258 @default.
• W69346578 hasRelatedWork W2109133991 @default.
• W69346578 hasRelatedWork W2121940992 @default.
• W69346578 hasRelatedWork W2133212933 @default.
• W69346578 hasRelatedWork W2165711586 @default.
• W69346578 hasRelatedWork W2528785712 @default.
• W69346578 hasRelatedWork W2801788191 @default.

• next